NO331218B1 - Transdermalt befruktningshindrende avleveringssystem - Google Patents

Transdermalt befruktningshindrende avleveringssystem

Info

Publication number
NO331218B1
NO331218B1 NO20022420A NO20022420A NO331218B1 NO 331218 B1 NO331218 B1 NO 331218B1 NO 20022420 A NO20022420 A NO 20022420A NO 20022420 A NO20022420 A NO 20022420A NO 331218 B1 NO331218 B1 NO 331218B1
Authority
NO
Norway
Prior art keywords
fertilization
transdermal
delivery system
prevention
prevention delivery
Prior art date
Application number
NO20022420A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022420L (no
NO20022420D0 (no
Inventor
Te-Yen Chien
Original Assignee
Agile Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agile Therapeutics Inc filed Critical Agile Therapeutics Inc
Publication of NO20022420D0 publication Critical patent/NO20022420D0/no
Publication of NO20022420L publication Critical patent/NO20022420L/no
Publication of NO331218B1 publication Critical patent/NO331218B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20022420A 1999-11-24 2002-05-22 Transdermalt befruktningshindrende avleveringssystem NO331218B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16753599P 1999-11-24 1999-11-24
PCT/US2000/032043 WO2001037770A1 (en) 1999-11-24 2000-11-22 Improved transdermal contraceptive delivery system and process

Publications (3)

Publication Number Publication Date
NO20022420D0 NO20022420D0 (no) 2002-05-22
NO20022420L NO20022420L (no) 2002-07-18
NO331218B1 true NO331218B1 (no) 2011-11-07

Family

ID=22607771

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022420A NO331218B1 (no) 1999-11-24 2002-05-22 Transdermalt befruktningshindrende avleveringssystem

Country Status (21)

Country Link
EP (1) EP1242012B1 (de)
JP (2) JP4841781B2 (de)
KR (1) KR100758757B1 (de)
CN (1) CN1399533A (de)
AR (1) AR030037A1 (de)
AT (1) ATE453374T1 (de)
AU (2) AU784196B2 (de)
BR (1) BR0015802B1 (de)
CA (1) CA2391430C (de)
CY (1) CY1110615T1 (de)
DE (1) DE60043621D1 (de)
DK (1) DK1242012T3 (de)
ES (1) ES2338860T3 (de)
IL (1) IL149655A0 (de)
MX (1) MXPA02005224A (de)
NO (1) NO331218B1 (de)
NZ (1) NZ518723A (de)
PT (1) PT1242012E (de)
TW (1) TWI253350B (de)
WO (1) WO2001037770A1 (de)
ZA (1) ZA200203525B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US7045145B1 (en) 1999-11-24 2006-05-16 Agile Therapeutics, Inc. Transdermal contraceptive delivery system and process
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
WO2004073696A1 (de) 2003-02-21 2004-09-02 Schering Ag Uv-stabiles transdermales pflaster
EP1624848A4 (de) * 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc Verfahren zur hormonbehandlung mit kontrazeptva-schemata mit verlängertem zyklus
MEP23508A (en) * 2003-10-28 2010-06-10 Noven Pharma Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
UA89766C2 (en) 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
CN1313084C (zh) * 2004-11-05 2007-05-02 郑会义 一种透皮避孕药传送体系及制备方法
CN1318032C (zh) * 2005-01-24 2007-05-30 浙江大学 炔雌醇透皮吸收贴片
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
US20080075779A1 (en) * 2006-09-27 2008-03-27 Chappa Ralph A Additives And Methods For Enhancing Active Agent Elution Kinetics
GB0809905D0 (en) * 2008-06-02 2008-07-09 Secr Defence A Transdermal drug delivery device
WO2011048613A2 (en) 2009-10-12 2011-04-28 Lyka Labs Limited Emergency contraceptive
RU2648827C2 (ru) * 2010-03-28 2018-03-28 Эвестра, Инк. Внутривлагалищное устройство для доставки лекарственного средства
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
KR20140088199A (ko) * 2011-11-04 2014-07-09 애자일 쎄라퓨틱스, 인크. 경피 전달 조성물 및 방법
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
EA030797B1 (ru) * 2012-12-21 2018-09-28 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Система трансдермальной доставки гормонов (варианты) и способы ее применения
US9314470B2 (en) 2012-12-28 2016-04-19 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
WO2016187269A1 (en) * 2015-05-18 2016-11-24 Agile Therapeutics, Inc. Contraceptive compositions and methods for improved efficacy and modulation of side effects
KR102652671B1 (ko) 2023-12-26 2024-03-29 주식회사 스몰랩 피임 마이크로니들용 미립구 조성물 및 이를 포함한 피임 마이크로니들

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632740A (en) * 1968-06-13 1972-01-04 Johnson & Johnson Topical device for the therapeutic management of dermatological lesions with steroids
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
CA2165802A1 (en) * 1993-09-29 1995-04-06 Eun Soo Lee Monoglyceride/lactate ester permeation enhancer for oxybutynin
PT742011E (pt) * 1994-11-17 2002-10-31 Toray Industries Preparacao que pode ser absorvida por via percutanea
CA2222133C (en) * 1995-06-07 2002-12-24 Cygnus, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US5762956A (en) * 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process

Also Published As

Publication number Publication date
DK1242012T3 (da) 2010-04-26
ES2338860T3 (es) 2010-05-13
AR030037A1 (es) 2003-08-13
EP1242012A1 (de) 2002-09-25
KR20020072280A (ko) 2002-09-14
JP2003533434A (ja) 2003-11-11
NO20022420L (no) 2002-07-18
AU2006201918A1 (en) 2006-06-01
JP2011231125A (ja) 2011-11-17
CA2391430C (en) 2009-10-06
DE60043621D1 (de) 2010-02-11
BR0015802A (pt) 2003-06-24
JP4841781B2 (ja) 2011-12-21
EP1242012A4 (de) 2006-05-31
WO2001037770A1 (en) 2001-05-31
AU784196B2 (en) 2006-02-23
ATE453374T1 (de) 2010-01-15
BR0015802B1 (pt) 2014-04-29
CA2391430A1 (en) 2001-05-31
IL149655A0 (en) 2002-11-10
PT1242012E (pt) 2010-03-31
TWI253350B (en) 2006-04-21
AU1788301A (en) 2001-06-04
EP1242012B1 (de) 2009-12-30
AU2006201918B2 (en) 2009-07-30
CN1399533A (zh) 2003-02-26
NZ518723A (en) 2004-04-30
KR100758757B1 (ko) 2007-09-14
MXPA02005224A (es) 2003-09-25
NO20022420D0 (no) 2002-05-22
CY1110615T1 (el) 2015-04-29
ZA200203525B (en) 2003-07-18

Similar Documents

Publication Publication Date Title
NO331218B1 (no) Transdermalt befruktningshindrende avleveringssystem
DE69832055D1 (de) Transdermales abgabesystem
DE60016271D1 (de) Medikamentenzuführvorrichtung
NO20004196L (no) Innretninger for legemiddelavlevering
DE60037203D1 (de) Medikamentenspender
NO20015193L (no) Betalingssystem
DE60020763D1 (de) Sterilisationssystem
DE50004430D1 (de) Fahrzeugelektrik-konfigurationssystem
DK1275397T3 (da) Lægemiddel til lokal anvendelse
IL137559A0 (en) Transdermal drug delivery system
DE60037935D1 (de) Kontinuierliches behandlungssystem
IS6163A (is) Lyfjakomplex
FI20001730A0 (fi) Lokasuojan kiinnitysjärjestelmä
DE50015688D1 (de) Pflastersteinsystem
DE60001315D1 (de) Verteilervorrichtung
NO995609D0 (no) AGC-system
NO20022013L (no) Innretninger for transdermal legemiddellevering
DE60000781D1 (de) Transaktionssystem
SE9904290D0 (sv) Polypertide delivery system
NO991931D0 (no) System for tyverisikring
DK1183061T3 (da) Lægemiddelafgivelsessystem
NO995100A (no) Fôrspreder
IL150334A0 (en) Transdermal drug delivery system
FI990143A7 (fi) Maksujärjestelmä
DE60029669D1 (de) Anzeigesystem

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees